Skip to main content
Top
Published in: Abdominal Radiology 1/2012

01-02-2012

MDCT assessment of ulcerative colitis: radiologic analysis with clinical, endoscopic, and pathologic correlation

Authors: Bijal Patel, Jeffrey Mottola, V. Anik Sahni, Vito Cantisani, Mehmet Ertruk, Sonia Friedman, Andrew M. Bellizzi, Andrea Marcantonio, Koenraad J. Mortele

Published in: Abdominal Radiology | Issue 1/2012

Login to get access

Abstract

Purpose

Evaluate the utility of multidetector-row computed tomography (MDCT) in assessing the severity of ulcerative colitis (UC) in comparison with clinical assessment, colonoscopy, and histopathology.

Materials and methods

Patients with UC evaluated with at least one abdominal contrast-enhanced CT study (CECT) within 7 days of colonoscopy with biopsy were included. CECT of 23 patients (12 male; mean age 40 years; age range, 20–72 years) were retrospectively evaluated in consensus by two radiologists. A total of 138 lower GI tract segments were evaluated by CECT and graded for the presence of bowel wall thickening, mucosal hyperenhancement, mural stratification, mesenteric hyperemia, pericolonic stranding, and lymph nodes. A cumulative CT severity score was calculated and correlated with clinical, colonoscopic, and histopathologic severity grades.

Results

The cumulative CT score and individual CECT scores for bowel wall thickening, mucosal hyperenhancement, and mural stratification showed positive correlation with clinical severity (P < 0.05). All individual CECT features as well as the cumulative CT score demonstrated statistically significant correlation with colonoscopic severity (P < 0.0001). Only wall thickening on CECT demonstrated significant correlation with histopathologic severity (P = 0.01).

Conclusion

Disease severity assessment by MDCT demonstrates positive correlation with severity established by clinical assessment and colonoscopy. Only increasing wall thickness, as graded on MDCT, correlates with histopathologic disease severity.
Literature
1.
go back to reference Viscado A, Aratari A, Maccioni F, Signore A, Caprilli R (2005) Inflammatory bowel diseases: clinical update of practical guidelines. Nucl Med Commun 26:649–655CrossRef Viscado A, Aratari A, Maccioni F, Signore A, Caprilli R (2005) Inflammatory bowel diseases: clinical update of practical guidelines. Nucl Med Commun 26:649–655CrossRef
3.
go back to reference Strange ER, Travis SP, Vermeire S, et al. (2008) European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2:1–23CrossRef Strange ER, Travis SP, Vermeire S, et al. (2008) European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2:1–23CrossRef
4.
go back to reference Lee SD, Cohen RD (2002) Endoscopy in inflammatory bowel disease. Gastroenterol Clin North Am 31:119–132PubMedCrossRef Lee SD, Cohen RD (2002) Endoscopy in inflammatory bowel disease. Gastroenterol Clin North Am 31:119–132PubMedCrossRef
5.
go back to reference Rimola J, Rodriguez S, Garcia-Bosch O, et al. (2009) Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease. RadioGraphics 29:701–719PubMedCrossRef Rimola J, Rodriguez S, Garcia-Bosch O, et al. (2009) Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease. RadioGraphics 29:701–719PubMedCrossRef
6.
go back to reference Kornbluth A, Sachar DB (2004) Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 9:1371–1385CrossRef Kornbluth A, Sachar DB (2004) Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 9:1371–1385CrossRef
7.
go back to reference Scotiniotis I, Rebesin SE, Ginsberg GG (1999) Imaging modalities in inflammatory bowel disease. Gastroenterol Clin North Am 28:391–421PubMedCrossRef Scotiniotis I, Rebesin SE, Ginsberg GG (1999) Imaging modalities in inflammatory bowel disease. Gastroenterol Clin North Am 28:391–421PubMedCrossRef
8.
go back to reference Theoni RF, Cello JP (2006) CT imaging of colitis. Radiology 240(3):623–638CrossRef Theoni RF, Cello JP (2006) CT imaging of colitis. Radiology 240(3):623–638CrossRef
9.
go back to reference Horton KM, Corl FM, Fishman EK (2000) CT evaluation of the colon: inflammatory disease. RadioGraphics 20:399–418PubMed Horton KM, Corl FM, Fishman EK (2000) CT evaluation of the colon: inflammatory disease. RadioGraphics 20:399–418PubMed
10.
go back to reference Rutgeerts P, Sandborn WJ, Feagan BG, et al. (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353(23):2462–2476PubMedCrossRef Rutgeerts P, Sandborn WJ, Feagan BG, et al. (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353(23):2462–2476PubMedCrossRef
11.
go back to reference Davis JA (1971) Elementary survey analysis. Englewood Cliffs, NJ: Prentice-Hall Davis JA (1971) Elementary survey analysis. Englewood Cliffs, NJ: Prentice-Hall
12.
go back to reference Fishman EK, Wolf EJ, Jones B, Bayless TM, Siegelman SS (1987) CT evaluation of Crohn’s disease: effect on patient management. AJR Am J Roentgenol 148:537–540PubMed Fishman EK, Wolf EJ, Jones B, Bayless TM, Siegelman SS (1987) CT evaluation of Crohn’s disease: effect on patient management. AJR Am J Roentgenol 148:537–540PubMed
13.
go back to reference Menees S, Higgins P, Korsnes S, Elta G (2007) Does colonoscopy cause increased ulcerative colitis symptoms? Inflamm Bowel Dis 13:12–18PubMedCrossRef Menees S, Higgins P, Korsnes S, Elta G (2007) Does colonoscopy cause increased ulcerative colitis symptoms? Inflamm Bowel Dis 13:12–18PubMedCrossRef
14.
go back to reference Gore RM, Balthazar EJ, Ghahremani GG, Miller FH (1996) CT features of ulcerative colitis and Crohn’s disease. AJR Am J Roentgenol 167(3):3–15PubMed Gore RM, Balthazar EJ, Ghahremani GG, Miller FH (1996) CT features of ulcerative colitis and Crohn’s disease. AJR Am J Roentgenol 167(3):3–15PubMed
15.
go back to reference Laufer I (1995) Radiology versus colonoscopy in evaluation of colonic IBD. Inflamm Bowel Dis 1:228–230CrossRef Laufer I (1995) Radiology versus colonoscopy in evaluation of colonic IBD. Inflamm Bowel Dis 1:228–230CrossRef
16.
go back to reference Way JD (1995) What is the best test for the patient with inflammatory bowel disease: colonoscopy or the barium enema? Inflamm Bowel Dis 1:231–232CrossRef Way JD (1995) What is the best test for the patient with inflammatory bowel disease: colonoscopy or the barium enema? Inflamm Bowel Dis 1:231–232CrossRef
17.
go back to reference Gore RM, Laufer I (1994) Ulcerative and granulomatous colitis: idiopathic inflammatory bowel disease. In: Gore RM, Levine MD, Laufer I (eds) Textbook of gastrointestinal radiology. Philadelphia: Saunders, pp 1098–1141 Gore RM, Laufer I (1994) Ulcerative and granulomatous colitis: idiopathic inflammatory bowel disease. In: Gore RM, Levine MD, Laufer I (eds) Textbook of gastrointestinal radiology. Philadelphia: Saunders, pp 1098–1141
18.
go back to reference Philpotts LE, Heiken JP, Westcott MA, Gore RM (1994) Colitis: use of CT findings in differential diagnosis. Radiology 190:445–449PubMed Philpotts LE, Heiken JP, Westcott MA, Gore RM (1994) Colitis: use of CT findings in differential diagnosis. Radiology 190:445–449PubMed
19.
go back to reference Wiesner W, Mortele KJ, Ji H, Ros PR (2002) Normal colonic wall thickness at CT and its relation to colonic distension. J Comput Assist Tomogr 26(1):102–106PubMedCrossRef Wiesner W, Mortele KJ, Ji H, Ros PR (2002) Normal colonic wall thickness at CT and its relation to colonic distension. J Comput Assist Tomogr 26(1):102–106PubMedCrossRef
20.
go back to reference Wittenberg J, Harisinghani MG, Jhaveri K, Varghese J, Mueller PR (2002) Algorithmic approach to CT diagnosis of the abnormal bowel wall. RadioGraphics 22:1093–1109PubMed Wittenberg J, Harisinghani MG, Jhaveri K, Varghese J, Mueller PR (2002) Algorithmic approach to CT diagnosis of the abnormal bowel wall. RadioGraphics 22:1093–1109PubMed
21.
go back to reference Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 137:1625–1629CrossRef Schroeder KW, Tremaine WJ, Ilstrup DM (1987) Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 137:1625–1629CrossRef
22.
go back to reference Maccioni F, Calaiacomo MC, Parlanti S (2005) Ulcerative colitis: value of MR imaging. Abdom Imaging 30:584–592PubMedCrossRef Maccioni F, Calaiacomo MC, Parlanti S (2005) Ulcerative colitis: value of MR imaging. Abdom Imaging 30:584–592PubMedCrossRef
23.
go back to reference Giovagnoni A, Misericordia M, Terilli F, et al. (1993) MR imaging of ulcerative colitis. Abdom Imaging 18:371–375PubMedCrossRef Giovagnoni A, Misericordia M, Terilli F, et al. (1993) MR imaging of ulcerative colitis. Abdom Imaging 18:371–375PubMedCrossRef
24.
go back to reference Riddell RH (2000) Pathology of idiopathic inflammatory bowel disease. In: Kirsner JB (ed) Inflammatory bowel disease, 5th edn. Philadelphia: WB Saunders, pp 427–447 Riddell RH (2000) Pathology of idiopathic inflammatory bowel disease. In: Kirsner JB (ed) Inflammatory bowel disease, 5th edn. Philadelphia: WB Saunders, pp 427–447
Metadata
Title
MDCT assessment of ulcerative colitis: radiologic analysis with clinical, endoscopic, and pathologic correlation
Authors
Bijal Patel
Jeffrey Mottola
V. Anik Sahni
Vito Cantisani
Mehmet Ertruk
Sonia Friedman
Andrew M. Bellizzi
Andrea Marcantonio
Koenraad J. Mortele
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9741-x

Other articles of this Issue 1/2012

Abdominal Radiology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.